Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportEducational Exhibits

Synthesis of 4-[18F]fluorophenyl-4'-nitrophenylcarbamate ([18F]FPNPC) and N-(4-[18F]fluorophenyl)-N-(2-maleimidoethyl)urea ([18F]FPMEU) for fluorine-18 labeling biomolecules

Wei-Yu Lin, Kan Liu, Sebastian Olma, Shannon Sirk, Eric Lepin, Tove Olafsen, Anna Wu and Clifton Kwang-Fu Shen
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1115;
Wei-Yu Lin
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kan Liu
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Olma
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shannon Sirk
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Lepin
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tove Olafsen
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Wu
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifton Kwang-Fu Shen
1Crump Institute for Molecular Imaging, Department of Molecular and Medical Pharmacology,David Geffen School of Medicine, UCLA, Los Angeles, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1115

Learning Objectives We developed two different 18F-tags, [18F]FPNPC and [18F]FPMEU, for radiolabeling of biomolecules. [18F]FPNPC can be used to react randomly with primary amines of lysines, while [18F]FPMEU can conjugate site-specifically to a thiol group of a cysteine.

Summary: A radiosynthesis of [18F]FPNPC following a described synthesis was carried out. Starting with the radiofluorination of dinitrobenzene to get 4-[18F]fluoronitrobenzene, reduction of the remaining nitro group using H3PO3 and Pd black resulted in 4-[18F]fluoroaniline. It was activated with 4-nitrophenylchloroformate to give a radiochemically pure [18F]FPNPC after three solid phase extraction (SPE) purifications. The RCY is up to 60% referred to [18F]F- after 65 min of synthesis. The novel thiophilic 18F-tag, [18F]FPMEU, can be obtained one step from [18F]FPNPC after reaction with N-(2-aminoethyl)maleimide. Within an additional 35 min, the final RCY is 40 % (n>10) after SPE purification. A HER2 targeting peptide (KGSGKCCYSL) was chosen as a model compound to be radiolabeled with [18F]FPNPC. After 15 min, high RCY can be achieved (70%). [18F]FPMEU conjugation also give high labeling yield (85%), with freshly prepared HER2-targeting peptide using TCEP as reducant agent for thiol group in 30 min. We are optimizing the entire reaction sequences so that it can be adaptable for automation and microfluidic-based radiolabeling. The biological evaluations are well under progress.

  • © 2009 by Society of Nuclear Medicine
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 50, Issue supplement 2
May 2009
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis of 4-[18F]fluorophenyl-4'-nitrophenylcarbamate ([18F]FPNPC) and N-(4-[18F]fluorophenyl)-N-(2-maleimidoethyl)urea ([18F]FPMEU) for fluorine-18 labeling biomolecules
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis of 4-[18F]fluorophenyl-4'-nitrophenylcarbamate ([18F]FPNPC) and N-(4-[18F]fluorophenyl)-N-(2-maleimidoethyl)urea ([18F]FPMEU) for fluorine-18 labeling biomolecules
Wei-Yu Lin, Kan Liu, Sebastian Olma, Shannon Sirk, Eric Lepin, Tove Olafsen, Anna Wu, Clifton Kwang-Fu Shen
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1115;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis of 4-[18F]fluorophenyl-4'-nitrophenylcarbamate ([18F]FPNPC) and N-(4-[18F]fluorophenyl)-N-(2-maleimidoethyl)urea ([18F]FPMEU) for fluorine-18 labeling biomolecules
Wei-Yu Lin, Kan Liu, Sebastian Olma, Shannon Sirk, Eric Lepin, Tove Olafsen, Anna Wu, Clifton Kwang-Fu Shen
Journal of Nuclear Medicine May 2009, 50 (supplement 2) 1115;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Educational Exhibits

  • Do They Work? Utilizing the "Hoshin Kanri" Process in the Nuclear Medicine Department
  • Challenges in F-18 FDG PET/CT: Benign Osseous Hypermetabolic Lesions
  • Early small bowel activity may predict rapid gastric transit on gastric emptying scintigraphy
Show more Educational Exhibits

Radiopharmaceutical Chemistry

  • We should be careful, activity in mCi or MBq doesn’t really measure what we want it to measure.
  • Drone delivery of imaging pharmaceuticals - Enabling technology for new distribution concepts - A case study for Kenya and beyond
  • Synthesis and labeling of a novel EGFR and HER-2 tyrosine kinase inhibitor containing 4-anilinoquinoline-3-carbonitrile nucleus
Show more Radiopharmaceutical Chemistry

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire